scispace - formally typeset
B

Barry M. Farr

Researcher at University of Virginia Health System

Publications -  47
Citations -  4942

Barry M. Farr is an academic researcher from University of Virginia Health System. The author has contributed to research in topics: Methicillin-resistant Staphylococcus aureus & Intensive care. The author has an hindex of 25, co-authored 47 publications receiving 4828 citations.

Papers
More filters
Journal ArticleDOI

SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus.

TL;DR: Active surveillance cultures are essential to identify the reservoir for spread of MRSA and VRE infections and make control possible using the CDC's long-recommended contact precautions, demonstrating consistency of evidence, high strength of association, reversibility, dose gradient, and specificity for control with this approach.
Journal ArticleDOI

Community-Acquired Methicillin-Resistant Staphylococcus aureus: A Meta-Analysis of Prevalence and Risk Factors

TL;DR: A meta-analysis of studies reporting the prevalence of community-acquired MRSA (CA-MRSA) among MRSA isolates from hospitalized patients or the prevalenceof MRSA colonization among community members suggested that effective control of dissemination of MRSA throughout the community likely will require effective controlOf nosocomial MRSA transmission.
Journal ArticleDOI

Influenza in the acute hospital setting

TL;DR: Optimal control of influenza in the acute-care setting should focus upon reducing potential influenza reservoirs in the hospital, including: isolating patients with suspected or documented influenza, sending home healthcare providers or staff who exhibit typical symptoms of influenza, and discouraging persons with febrile respiratory illness from visiting the hospital during a known influenza outbreak in the community.
Journal ArticleDOI

Preventing nosocomial influenza by improving the vaccine acceptance rate of clinicians.

TL;DR: A mobile cart vaccination program and an increased emphasis on HCWs to receive the vaccine were associated with a significant increase in vaccine acceptance and a significant decrease in the rate of nosocomial influenza among patients.
Journal ArticleDOI

Incubation period and sources of exposure for cutaneous Mycobacterium marinum infection: case report and review of the literature.

TL;DR: Patients with atypical cutaneous infections should be questioned about high-risk exposures that may have occurred up to 9 months before the onset of symptoms, because the incubation period for cutaneous M. marinum infection can be prolonged.